CF PharmTech was founded in 2007, it is a fully independent, dynamic, integrated, specialty pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market. Its mission is to develop high-quality and affordable medicine to help patients achieve effective management care for their respiratory diseases. The headquarters is located in the lakeside of the Caohu District of Suzhou, Jiangsu Province, with many very convenient transportation options available. It only takes thirty minutes by train to Shanghai and four hours by train to Beijing.
Total raised: $205M
Investors 3
Funding Rounds 3
Date | Series | Amount | Investors |
02.07.2020 | Series F | $50M | - |
02.01.2020 | Series E | $90M | - |
28.08.2017 | Series D | $65M | - |
Mentions in press and media 6
Date | Title | Description | Source |
03.07.2020 | CF PharmTech Closes US$50M Series F Financing | CF PharmTech’s manufacturing facility CF PharmTech, Inc., a Suzhou, China-based maker of inhalation... | finsmes.co... |
02.07.2020 | China’s CF PharmTech bags $50m in Series F round | Premium Chinese respiratory disease-focused pharmaceutical company CF PharmTech, Inc on Thursday sa... | dealstreet... |
02.01.2020 | CF PharmTech Raises $90M in Series E Funding | CF PharmTech’s manufacturing facility CF PharmTech, Inc., a Shuzhou, China-based pharmaceutical com... | finsmes.co... |
02.01.2020 | China’s CF PharmTech raises $90m Series E led by New Allianc... | Premium Chinese pharma company CF PharmTech, Inc has raised $90 million in its Series E round led b... | dealstreet... |
29.08.2017 | Term Sheet — Tuesday, August 29 | THREE THINGS Good morning, Term Sheet readers. Paid Content Securing the enterprise without bounda... | fortune.co... |
28.08.2017 | CF PharmTech Raises $65M in Series D Financing | CF PharmTech, Inc., a Suzhou, China-based specialty pharmaceutical company that develops and manufac... | finsmes.co... |